Sparks commentary

Healthcare

Sparks

Umecrine Cognition receives grant from the MJFF
Published by Arron Aatkar, PhD

Umecrine Cognition has announced that it has received a US$420k research grant from the The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The funding will be utilised to conduct preclinical research to assess the potential of  golexanolone in Parkinson’s disease. More specifically, it will look at the treatment effect of the candidate in models of Parkinson’s-related sleep dysfunction and cognitive impairments. The grant will be disbursed in three installments over the next two years.

Latest

Healthcare | Comment

Herantis Pharma (HEL: HRTIS) – a step closer to Phase II

Investment Companies | Comment

The Biotech Growth Trust (BIOG) reported encouraging H126 results

TMT | Comment

Nanoco (LSE:NANO) settles LG litigation for $5m

Healthcare | Comment

Mendus (OMX: IMMU) announces c SEK50m directed share issue